ACCA考试《公司法与商法》章节练习(2020-08-12)
发布时间:2020-08-12
备考是一条艰辛而又漫长的旅程,只有掌握了学习方法,才能轻松应对。为了帮助大家更好的备考,下面51题库考试学习网给大家分享一些ACCA考试《公司法与商法》试题,备考的小伙伴赶紧来练练手吧。
Please use the space provided on the inside
cover of the Candidate Answer Booklet to indicate your chosen answer to each
multiple choice question.
1 Which of the following involves an offer
which may only be accepted by performing an action?
A、A collateral
contract
B、 A unilateral
contract
C、A bilateral
contract
2 An agency relationship which is made
retrospectively is referred to by which of the following terms?
A、 Agency by
estoppel
B、 Agency by
ratification
C、Agency by
necessity
3 In contract law, the ‘market price rule’
arises in relation to which of the following?
A、 Offer
B 、Consideration
C、 Remoteness
D、 Mitigation
4 In relation to a debenture, which of the
following is NOT true?
A 、It may be issued
at a discount
B、 Interest on it
may be paid from capital
C、 It is paid after
preference shares
D、It is freely
transferable
5 Tan writes to Yun stating that he will
sell his car to him for £10,000. At the same time, Yun
writes to Tan stating that he will buy his car for £10,000.
Which of the following statements applies to this situation?
A、There is a
binding agreement due to the postal rule
B、There is a
collateral contract
C、 There is neither
an agreement nor a contract
6 Which of the following statements about
contracts of employment is true?
A、They can be made
either orally or in writing
B、 They must be
made in writing
C、They must be
evidenced in writing
7 Where directors make a false statement of
solvency prior to a members’ voluntary liquidation, which of the following have
they committed under the relevant legislation?
A、 A breach of
criminal law with criminal penalties
B、A breach of civil
law with criminal penalties
C、A breach of civil
law with civil liability
D、 A breach of both
civil and criminal law with liabilities under both
8 Which of the following is the consequence
when a patient signs a medical consent form before an operation?
A、 The patient
gives up any right of action for any injury suffered
B 、Any action for
any injury suffered during the operation is limited to negligence
C 、The level of any
potential payment for any injury suffered is reduced
9 Where a contract states the sum to be
paid in the event of a breach of contract, the stated sum is known as which of
the following?
A、Unliquidated
damages
B、 Liquidated
damages
C、Specific damages
D、 Nominal damages
10 Which of the following applies to the
concept of enlightened shareholder value?
A、 It is the price
shares can be expected to raise if they were to be sold
B、It is the
yardstick for assessing the performance of directors’ duties
C、 It is the
standard of behaviour expected of shareholders in general meetings
Answer:
1 、B
2 、B
3、 D
4 、C
5 、C
6、 A
7、 A
8 、B
9、 B
10 、B
以上就是本次51题库考试学习网分享给大家的关于ACCA考试《公司法与商法》试题,如果大家对于ACCA考试还有别的问题,可以多多关注51题库考试学习网,我们将继续为大家答疑解惑!
下面小编为大家准备了 ACCA考试 的相关考题,供大家学习参考。
4 The Better Agriculture Group (BAG), which has a divisional structure, produces a range of products for the farming
industry. Divisions B and C are two of its divisions. Division B sells a fertiliser product (BF) to customers external to
BAG. Division C produces a chemical (CC) which it could transfer to Division B for use in the manufacture of its
product BF. However, Division C could also sell some of its output of chemical CC to external customers of BAG.
An independent external supplier to The Better Agriculture Group has offered to supply Division B with a chemical
which is equivalent to component CC. The independent supplier has a maximum spare capacity of 60,000 kilograms
of the chemical which it is willing to make available (in total or in part) to Division B at a special price of $55 per
kilogram.
Forecast information for the forthcoming period is as follows:
Division B:
Production and sales of 360,000 litres of BF at a selling price of $120 per litre.
Variable conversion costs of BF will amount to $15 per litre.
Fixed costs are estimated at $18,000,000.
Chemical (CC) is used at the rate of 1 kilogram of CC per 4 litres of product BF.
Division C:
Total production capacity of 100,000 kilograms of chemical CC.
Variable costs will be $50 per kilogram of CC.
Fixed costs are estimated at $2,000,000.
Market research suggests that external customers of BAG are willing to take up sales of 40,000 kilograms of CC at a
price of $105 per kilogram. The remaining 60,000 kilograms of CC could be transferred to Division B for use in
product BF. Currently no other market external to BAG is available for the 60,000 kilograms of CC.
Required:
(a) (i) State the price/prices per kilogram at which Division C should offer to transfer chemical CC to Division
B in order that the maximisation of BAG profit would occur if Division B management implement rational
sourcing decisions based on purely financial grounds.
Note: you should explain the basis on which Division B would make its decision using the information
available, incorporating details of all relevant calculations. (6 marks)
(a) (i) In order to facilitate BAG profit maximising decisions the following strategy should apply:
Division C should offer to transfer chemical CC to Division B at marginal cost plus opportunity cost. This would apply
as follows:
– 40,000 kilograms of CC at $105 per kilogram since this is the price that could be achieved from sales to external
customers of BAG.
– 60,000 kilograms of CC at marginal cost of $50 per kilogram since no alternative opportunity exists.
Division B has a sales forecast of 360,000 litres of product BF. This will require 360,000/4 = 90,000 kilograms of
chemical CC input.
Based on the pricing by Division C indicated above, Division B would choose to purchase 60,000 kilograms of CC from
Division C at $50 per kilogram, since this is less than the $55 per kilogram quoted by the independent supplier.
Division B would purchase its remaining requirement for 30,000 kilograms of CC from the independent supplier at $55
per kilogram since this is less than the $105 per kilogram at which Division C would offer to transfer its remaining output
– given that it can sell the residual output to external customers of BAG.
(b) Calculate the amount of input tax that will be recovered by Vostok Ltd in respect of the new premises in the
year ending 31 March 2009 and explain, using illustrative calculations, how any additional recoverable input
tax will be calculated in future years. (5 marks)
(b) Recoverable input tax in respect of new premises
Vostok Ltd will recover £47,880 (£446,500 x 7/47 x 72%) in the year ending 31 March 2009.
The capital goods scheme will apply to the purchase of the building because it is to cost more than £250,000. Under the
scheme, the total amount of input tax recovered reflects the use of the building over the period of ownership, up to a maximum
of ten years, rather than merely the year of purchase.
Further input tax will be recovered in future years as the percentage of exempt supplies falls. (If the percentage of exempt
supplies were to rise, Vostok Ltd would have to repay input tax to HMRC.)
The additional recoverable input tax will be computed by reference to the percentage of taxable supplies in each year including
the year of sale. For example, if the percentage of taxable supplies in a particular subsequent year were to be 80%, the
additional recoverable input tax would be computed as follows.
£446,500 x 7/47 x 1/10 x (80% – 72%) = £532.
Further input tax will be recovered in the year of sale as if Vostok Ltd’s supplies in the remaining years of the ten-year period
are fully vatable. For example, if the building is sold in year seven, the additional recoverable amount for the remaining three
years will be calculated as follows.
£446,500 x 7/47 x 1/10 x (100% – 72%) x 3 = £5,586.
3 You are the manager responsible for the audit of Seymour Co. The company offers information, proprietary foods and
medical innovations designed to improve the quality of life. (Proprietary foods are marketed under and protected by
registered names.) The draft consolidated financial statements for the year ended 30 September 2006 show revenue
of $74·4 million (2005 – $69·2 million), profit before taxation of $13·2 million (2005 – $15·8 million) and total
assets of $53·3 million (2005 – $40·5 million).
The following issues arising during the final audit have been noted on a schedule of points for your attention:
(a) In 2001, Seymour had been awarded a 20-year patent on a new drug, Tournose, that was also approved for
food use. The drug had been developed at a cost of $4 million which is being amortised over the life of the
patent. The patent cost $11,600. In September 2006 a competitor announced the successful completion of
preliminary trials on an alternative drug with the same beneficial properties as Tournose. The alternative drug is
expected to be readily available in two years time. (7 marks)
Required:
For each of the above issues:
(i) comment on the matters that you should consider; and
(ii) state the audit evidence that you should expect to find,
in undertaking your review of the audit working papers and financial statements of Seymour Co for the year ended
30 September 2006.
NOTE: The mark allocation is shown against each of the three issues.
■ A change in the estimated useful life should be accounted for as a change in accounting estimate in accordance
with IAS 8 Accounting Policies, Changes in Accounting Estimates and Errors. For example, if the development
costs have little, if any, useful life after the introduction of the alternative drug (‘worst case’ scenario), the carrying
value ($3 million) should be written off over the current and remaining years, i.e. $1 million p.a. The increase in
amortisation/decrease in carrying value ($800,000) is material to PBT (6%) and total assets (1·5%).
■ Similarly a change in the expected pattern of consumption of the future economic benefits should be accounted for
as a change in accounting estimate (IAS 8). For example, it may be that the useful life is still to 2020 but that
the economic benefits may reduce significantly in two years time.
■ After adjusting the carrying amount to take account of the change in accounting estimate(s) management should
have tested it for impairment and any impairment loss recognised in profit or loss.
(ii) Audit evidence
■ $3 million carrying amount of development costs brought forward agreed to prior year working papers and financial
statements.
■ A copy of the press release announcing the competitor’s alternative drug.
■ Management’s projections of future cashflows from Tournose-related sales as evidence of the useful life of the
development costs and pattern of consumption.
■ Reperformance of management’s impairment test on the development costs: Recalculation of management’s
calculation of the carrying amount after revising estimates of useful life and/or consumption of benefits compared
with management’s calculation of value in use.
■ Sensitivity analysis on management’s key assumptions (e.g. estimates of useful life, discount rate).
■ Written management representation on the key assumptions concerning the future that have a significant risk of
causing material adjustment to the carrying amount of the development costs. (These assumptions should be
disclosed in accordance with IAS 1 Presentation of Financial Statements.)
(ii) The recoverability of the deferred tax asset. (4 marks)
(ii) Principal audit procedures – recoverability of deferred tax asset
– Obtain a copy of Bluebell Co’s current tax computation and deferred tax calculations and agree figures to any
relevant tax correspondence and/or underlying accounting records.
– Develop an independent expectation of the estimate to corroborate the reasonableness of management’s estimate.
– Obtain forecasts of profitability and agree that there is sufficient forecast taxable profit available for the losses to be
offset against. Evaluate the assumptions used in the forecast against business understanding. In particular consider
assumptions regarding the growth rate of taxable profit in light of the underlying detrimental trend in profit before
tax.
– Assess the time period it will take to generate sufficient profits to utilise the tax losses. If it is going to take a number
of years to generate such profits, it may be that the recognition of the asset should be restricted.
– Using tax correspondence, verify that there is no restriction on the ability of Bluebell Co to carry the losses forward
and to use the losses against future taxable profits.
Tutorial note: in many tax jurisdictions losses can only be carried forward to be utilised against profits generated
from the same trade. Although in the scenario there is no evidence of such a change in trade, or indeed any kind
of restriction on the use of losses, it is still a valid audit procedure to verify that this is the case
声明:本文内容由互联网用户自发贡献自行上传,本网站不拥有所有权,未作人工编辑处理,也不承担相关法律责任。如果您发现有涉嫌版权的内容,欢迎发送邮件至:contact@51tk.com 进行举报,并提供相关证据,工作人员会在5个工作日内联系你,一经查实,本站将立刻删除涉嫌侵权内容。
- 2019-03-15
- 2020-08-12
- 2020-08-12
- 2020-08-12
- 2020-08-12
- 2020-08-12
- 2020-08-12
- 2020-08-12
- 2020-08-12
- 2019-03-15
- 2020-08-12
- 2020-08-12
- 2020-08-12
- 2020-08-12
- 2020-08-12
- 2020-08-12
- 2020-08-12
- 2020-08-12
- 2020-08-12
- 2020-08-12
- 2019-03-15
- 2020-08-12
- 2020-08-12
- 2020-08-12
- 2020-08-12
- 2020-08-12
- 2020-08-12